Pulmonary protective effects of PCV-VG versus VCV on patients with one-lung ventilation undergoing thoracoscopic pneumectomy

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300068500

Enrollment

Unknown

Registered

2023-02-21

Start date

2022-09-01

Completion date

Unknown

Last updated

2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pulmonary complications

Interventions

Group PCV-VG:Pressure control ventilation with volume guarantee

Group VCV:Volume controlled ventilation

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age> 18 years old2. ASA I-III grade3.Scheduled for resection of thoracoscopic wedge, segment, and lobectomy4. Sign informed consent

Exclusion criteria

Exclusion criteria: 1.Patients with a history of lung surgery2.Patients with a history of mechanical ventilation within 2 weeks before surgery or history of respiratory failure3.New York Heart Association classification Grade IV5. Chronic renal failure

Design outcomes

Primary

Measure	Time frame
Postoperative pulmonary complications;	—

Secondary

Measure	Time frame
Heart rate;arterial pressure;PaO2;CRP;Tidal volume;Simple cough score;Cough daytime and nighttime symptom score;Borg dyspnea score;PETCO2;Ppeak;Cough symptoms VAS;Cdyn of Ppeak;Pulse oximetry;Respiratory rate, RR;Hospital stay;Drainage tube withdrawal time;	—

Countries

China

Contacts

Public ContactZhao Wenjing

The Affiliated Hospital of Xuzhou Medical University

Zhaowj886@sina.com13852157285

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026